Friday, February 22, 2008

The Great 2008 Medgadget Debate

Filed under: Medgadget Exclusive

Reuters, the wire service, has just published what looks to us as nothing less than an editorial about politics and medical devices. The article, titled "Medtech firms see benefit from Democratic plans", claims that the current presidential nominee lineup, especially coming from the side of the Democrats, is a good omen for makers of medical devices. The basic claim, supposedly supported by Advamed, an industry association, is that greater mandated medical coverage of the population will lead to higher sales of medical devices.

Undoubtedly, as was pointed out in the Reuters article, things aren't so simple. In reality the situation is that politicians are leaning towards controlling pharmaceutical prices as a method to keep already skyrocketing healthcare (Medicare, really) costs down, and medical devices are naturally next in line.

Of course the nominee plans call for more spending on top of a system that is already generating debt everyday. Given that the healthcare industry is already close to capacity, an infusion of approximately another 100 million people should, if the free market exists, drive through the roof the already high cost of medicine. This last sentence assumes that additional patients are actually additional consumers creating extra demand within the old supply/demand charts. In reality, instead of creating additional individual consumers that participate in the mechanics of the free market, the tendency, at least from the Democrats, is to lump these people and insure them through the government, creating the dreaded "single payer" entity that exists the world over. Just like a monopoly supplier that can set prices, the monopoly consumer has almost universal mandate powers to make manufacturers submit to its whim.

Moreover, a monopoly consumer in the form of an indebted state, where the legislation-writing individuals fear no personal loss (being neither patients receiving care, nor the ones that directly pay for it), have a much easier time of demanding cheap supplies, while having no scruples of limiting provided care. The result, given enough time, is a system where neither the patients nor medical suppliers are making any decisions anymore, but are mandated by the state to produce so many syringes at given prices for a stated population, and for the patient to receive this or that treatment and no more.

We believe there is a reason why the pages of Medgadget are dominated by American medical technology. We believe that is thanks to a multitude of independent manufacturers and suppliers, as well as the millions of unique individuals with different conditions, calculations of cost/benefit, and individually suited health insurance plans from hundreds of competing companies.

American healthcare is indeed going through an important period that requires specific changes, and yet one must keep in mind the strong, unyielding forces that come to life when bureaucrats take over and a critical industry such as healthcare is taken from the civilian world to the political. Perhaps Reuters will consider long term consequences of more interest to ponder than short term results provided on borrowed terms.

email this article to a friend      print this!           comments and peer reviews (1)






replies: 1 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.

Yes, this post is right on. The US has the most innovative medical market in the world, largely in part because we don't have a universal healthcare system. Universal healthcare ultimately leads to price controls which can have a chilling effect on medical innovation. Europe used to have a much better pharmaceutical market, but it has declined considerably since the introduction of price controls. Price controls are often well intentioned, but they usually have a negative impact on the market. Any Medtech firm that thinks the democrats will be good for their bussiness is just plain wrong. The democrats are likely to turn this country towards more price controls which will inevitably reduce medical innovation by curtailing profits that a company can get. To say that a universal healthcare system will give Medtech companies "more customers" is totally erroneous. The true cost of price controls comes from the lives that will belost because innovative life saving medical technology never gets to market. Unfortunately these things are harder to measure, so they are often ignored by politicians. Populist politicians will make the public believe that they can make money appear out of nowhere, when they can do no such thing. The move towards more medical socialism is likely to result in a significanlty reduced innovative capacity of the US market and lives lost as a result. The reason that healthcare costs are spiraling out of control is not because older technology is getting more expensive. It's because we are getting new and better technology. The free market works best in getting the price down on technology. That is the reason you can buy a flat screen television for under 1,000 now, when ten years ago it cost nearly 20,000. A lot of medical technology is much cheaper now (MRI's, X-rays) because companies are allowed to compete and get the price down. Price controls will reduce the incentive for companies to get prices lower. So in the long term it may actually be more expensive to have price controls. Curtailing the US market could lead to much more suffering due to fewer technologies being produced.


Posted by: Mike
on February 22, 2008 03:48 PM GMT

add a comment
html tags: <b>, <i>, and <a>
examples: <b>Bold</b> <i>Italic</i>









Remember personal info?
(anonymous comments allowed)



click to make your selection boldclick to make your selection italicclick to add a link


Verification (needed to reduce spam):




Click the "Post" button only once!